|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| (Loss) / profit for the year | |||||
| Adjustments for: | |||||
| Income tax expense / (benefit) | |||||
| Depreciation | |||||
| Amortization | |||||
| Depreciation of right of use assets | |||||
| (Gain) / loss from the disposal of other property items | |||||
| Gain from the sale of farmland and other assets | |||||
| Bargain purchase gain on acquisition | |||||
| (Insurance recovery) / impairment due to fire | |||||
| Net (gain) / loss from the fair value adjustment of Investment properties | |||||
| Equity settled share-based compensation granted | |||||
| (Gain) from derivative financial instruments and forwards | |||||
| Interest, finance cost related to lease liabilities and other financial expense, net | |||||
| Initial recognition and changes in fair value of non-harvested biological assets (unrealized) | |||||
| Changes in net realizable value of agricultural produce after harvest (unrealized) | |||||
| Provision and allowances | |||||
| Tax credits recognized | |||||
| Net loss / (gain) of inflation effects on the monetary items | |||||
| Foreign exchange (gain) / losses, net | |||||
| Cash flow hedge – transfer from equity | |||||
| Subtotal | |||||
| Changes in operating assets and liabilities: | |||||
| (Increase) / decrease in trade and other receivables | |||||
| Decrease / (increase) in inventories | |||||
| Increase in biological assets | |||||
| Decrease / (increase) in other assets | |||||
| Decrease / (increase) in derivative financial instruments | |||||
| Decrease in trade and other payables | |||||
| Increase in payroll and social security liabilities | |||||
| Increase in provisions for other liabilities | |||||
| Net cash generated from operating activities before taxes paid | |||||
| Income tax paid | |||||
| Net cash generated from operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of subsidiaries net of cash and cash equivalents acquired | |||||
| Purchases of property, plant and equipment | |||||
| Purchase of cattle and non-current biological assets | |||||
| Purchases of intangible assets | |||||
| Interest received and others | |||||
| Proceeds from disposal of other property items | |||||
| Proceeds from the sale of farmland and other assets | |||||
| Proceeds from the sale of subsidiary | |||||
| Acquisition of short-term investment | |||||
| Disposals of short-term investment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of shares net of transaction costs | |||||
| Proceeds from long-term borrowings | |||||
| Payments of long-term borrowings | |||||
| Proceeds from short-term borrowings | |||||
| Payments of short-term borrowings | |||||
| Interest paid | |||||
| Borrowings prepayment related expenses | |||||
| Proceeds from exercise of employee share options | |||||
| (Payments) / collections of derivatives financial instruments | |||||
| Lease payments | |||||
| Purchase of own shares | |||||
| Dividends paid to non-controlling interest | |||||
| Dividends paid to shareholders | |||||
| Net cash used in financing activities | |||||
| Net (decrease) / increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Effect of exchange rate changes and inflation on cash and cash equivalents | |||||
| Cash and cash equivalents at end of year | |||||
Loading...